Vistara™ Single-Gene NIPT
Use
Vistara™ is a prenatal single-gene screening test designed to identify serious genetic conditions that could significantly impact quality of life. The test screens for 25 autosomal dominant and X-linked conditions by analyzing 30 genes. Detection of such conditions can guide early interventions, informing pregnancy and delivery management decisions. Due to its comprehensive scope, Vistara™ offers clinically actionable insights not typically accessible through standard non-invasive prenatal testing alone.
Special Instructions
Vistara™ requires only a single blood draw from the mother. There is no need for a paternal or egg-donor sample unless specifically applicable. The test results can be integrated into any office setting. Additionally, Vistara™ is an adjunct to traditional diagnostic procedures such as chorionic villus sampling (CVS) and amniocentesis, and findings can be confirmed using the original diagnostic sample without the need for additional procedures.
Limitations
Vistara™ is a screening tool and not a diagnostic test. It means that while the test can indicate an increased risk of certain conditions, it cannot provide a definitive diagnosis. A screen-positive result suggests a possibility of the condition, but further diagnostic testing is needed to confirm whether the fetus is affected. Prenatal diagnostic testing during pregnancy, such as amniocentesis or chorionic villus sampling (CVS), is recommended for confirmation.
Methodology
NGS (Targeted)
Biomarkers
Result Turnaround Time
2-3 weeks
Related Documents
For more information, please review the documents below
Specimen
Whole Blood
Volume
Not provided
Minimum Volume
Not provided
Collection Instructions
With only one blood draw from the mother required, the test can be ordered seamlessly.